$8.32
-0.36-4.15%
Last update: Nov 4, 4:00 PM
Atrium Therapeutics Inc
RNANASDAQ
The average analyst price target for Atrium Therapeutics is $57.62, 563.8% above the current price. Of 18 analysts, 11 rate it Buy and 7 Hold. Targets range from $15 to $96. The latest change came on Oct 28, 2026, when HC Wainwright & Co. lowered its price target on Atrium Therapeutics from $25 to $20 and kept a Buy rating.
Price Target Range — 13 Quarters
Analyst Consensus — 18 Analysts
Rating Trend — Last 9 Months
